CRL · ISSUER CIK 1100682
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Between Jul 31, 2026 and Oct 28, 2026, 8 CHARLES RIVER LABORATORIES INTERNATIONAL, INC. insiders reported $3K of open-market purchases and $35.2M of sales on SEC Form 4. The largest buyer was Coleman Glenn (EVP & Chief Financial Officer), with $3K.
↗8 insiders filed
Original Form 4 filings from Jul 31, 2026 to Oct 28, 2026. 9 of 12 sales were reported under a 10b5-1 plan.
$3KInsider buying
$35.2MInsider selling
−$35.2MNet open-market
Oct 26, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 26, 202616:51 | Oct 22, 2026 | CRL | Director | S · Sell10b5-1 | $350.00 | −24,042 | 31,596 | -43% | −$8.4M | ||
| Oct 26, 202616:51 | Oct 22, 2026 | CRL | Director | M · Exercise10b5-1 | $244.41 | +24,042 | 55,638 | +76% | $5.9M | ||
| Oct 23, 202618:45 | Oct 21, 2026 | CRL | CEVP, Disc & Safety Assessment | S · Sell10b5-1 | $344.41 | −2,156 | 4,807 | -31% | −$743K | ||
| Oct 23, 202618:45 | Oct 21, 2026 | CRL | CEVP, Disc & Safety Assessment | M · Exercise10b5-1 | $244.41 | +2,156 | 6,963 | +45% | $527K | ||
| Oct 7, 202620:32 | Oct 5, 2026 | CRL | CEVP, Disc & Safety Assessment | S · Sell10b5-1 | $308.44 | −981 | 4,807 | -17% | −$303K | ||
| Oct 7, 202620:32 | Oct 5, 2026 | CRL | CEVP, Disc & Safety Assessment | M · Exercise10b5-1 | $208.44 | +981 | 5,788 | +20% | $204K | ||
| Oct 2, 202616:27 | Sep 30, 2026 | CRL | EVP & Chief Financial Officer | P · Buy | $297.43 | +10 | 27,762 | +0% | +$3K | -0.4% | +25.7% |
| Aug 27, 202616:21 | Aug 25, 2026 | CRL | Director | S · Sell10b5-1 | $300.00 | −33,561 | 31,596 | -52% | −$10.1M | ||
| Aug 27, 202616:21 | Aug 25, 2026 | CRL | Director | M · Exercise10b5-1 | $199.42 | +33,561 | 65,157 | +106% | $6.7M | ||
| Aug 20, 202616:37 | Aug 19, 2026 | CRL | Chief Executive Officer, Director | G · Gift | — | −528 | 35,485 | -1% | — | ||
| Aug 20, 202616:33 | Aug 19, 2026 | CRL | CEVP, Disc & Safety Assessment | S · Sell10b5-1 | $294.12 | −2,039 | 4,807 | -30% | −$600K | ||
| Aug 20, 202616:33 | Aug 19, 2026 | CRL | CEVP, Disc & Safety Assessment | M · Exercise10b5-1 | $194.12 | +2,039 | 6,846 | +42% | $396K | ||
| Aug 20, 202616:31 | Aug 18, 2026 | CRL | Director | S · Sell | $285.24 | −573 | 1,438 | -28% | −$163K | ||
| Aug 20, 202616:31 | Aug 18, 2026 | CRL | Director | M · Exercise | $164.30 | +573 | 2,011 | +40% | $94K | ||
| Aug 13, 202616:37 | Aug 11, 2026 | CRL | Chief Executive Officer, Director | S · Sell10b5-1 | $279.90 | −6,500 | 36,013 | -15% | −$1.8M | ||
| Aug 13, 202616:37 | Aug 11, 2026 | CRL | Chief Executive Officer, Director | M · Exercise10b5-1 | $179.66 | +6,500 | 42,513 | +18% | $1.2M | ||
| Aug 13, 202616:34 | Aug 11, 2026 | CRL | CEVP, Disc & Safety Assessment | S · Sell10b5-1 | $279.66 | −3,714 | 4,807 | -44% | −$1.0M | ||
| Aug 13, 202616:34 | Aug 11, 2026 | CRL | CEVP, Disc & Safety Assessment | M · Exercise10b5-1 | $179.66 | +3,714 | 8,521 | +77% | $667K | ||
| Aug 11, 202616:38 | Aug 10, 2026 | CRL | EVP, Corp Strategy & Develop | G · Gift | — | −257 | 31,041 | -1% | — | ||
| Aug 11, 202616:35 | Aug 10, 2026 | CRL | Director | S · Sell10b5-1 | $275.00 | −28,733 | 31,596 | -48% | −$7.9M | ||
| Aug 11, 202616:35 | Aug 10, 2026 | CRL | Director | M · Exercise10b5-1 | $179.66 | +28,733 | 60,329 | +91% | $5.2M | ||
| Aug 10, 202616:40 | Aug 6, 2026 | CRL | SVP, Finance and CAO | S · Sell | $260.38 | −6,645 | 11,852 | -36% | −$1.7M | ||
| Aug 10, 202616:40 | Aug 6, 2026 | CRL | SVP, Finance and CAO | M · Exercise | $196.12 | +2,345 | 14,197 | +20% | $460K | ||
| Aug 10, 202616:35 | Aug 6, 2026 | CRL | EVP & Chief People Officer | S · Sell | $259.16 | −4,179 | 30,051 | -12% | −$1.1M | ||
| Aug 10, 202616:35 | Aug 6, 2026 | CRL | EVP & Chief People Officer | M · Exercise | $179.66 | +4,179 | 34,230 | +14% | $751K | ||
| Aug 6, 202616:49 | Aug 5, 2026 | CRL | CEVP, Disc & Safety Assessment | S · Sell10b5-1 | $263.00 | −5,046 | 4,807 | -51% | −$1.3M |